Pragmatic randomised controlled trial of a personalised intervention for carers of people requiring home oxygen therapy

Autor: Suzanne Van Asten, Khin Hnin, Ruth Sladek, Mary A. Luszcz, Richard J. Woodman, Simon Eckermann, Tanja W. Effing, Debra Rowett, Paul Cafarella, Paddy A. Phillips, Tina Jones, Sandra L Bradley, Peter Frith
Přispěvatelé: Frith, Peter, Sladek, Ruth, Woodman, Richard, Effing, Tanja, Bradley, Sandra, van Asten, Suzanne, Jones, Tina, Hnin, Khin, Luszcz, Mary, Cafarella, Paul, Eckermann, Simon, Rowett, Debra, Phillips, Paddy A, Internal medicine
Jazyk: angličtina
Rok vydání: 2020
Předmět:
Male
Pulmonary and Respiratory Medicine
medicine.medical_specialty
caregivers
Psychological intervention
Chronic disease
law.invention
behavioural research
Pulmonary Disease
Chronic Obstructive

03 medical and health sciences
0302 clinical medicine
Randomized controlled trial
law
Intervention (counseling)
Outcome Assessment
Health Care

Humans
Medicine
030212 general & internal medicine
Karnofsky Performance Status
Health Education
Life Style
Aged
Original Paper
COPD
education
business.industry
Self-Management
Hazard ratio
Australia
Oxygen Inhalation Therapy
Interstitial lung disease
medicine.disease
Home Care Services
Long-Term Care
Confidence interval
3. Good health
Hospitalization
Oxygen
Clinical trial
Mental Health
Treatment Outcome
Editorial
030228 respiratory system
Physical therapy
Female
business
chronic disease
oxygen
Zdroj: Frith, P, Sladek, R, Woodman, R, Effing, T, Bradley, S, van Asten, S, Jones, T, Hnin, K, Luszcz, M, Cafarella, P, Eckermann, S, Rowett, D & Phillips, P A 2020, ' Pragmatic randomised controlled trial of a personalised intervention for carers of people requiring home oxygen therapy ', Chronic Respiratory Disease, vol. 17 . https://doi.org/10.1177/1479973119897277
Chronic Respiratory Disease
Chronic Respiratory Disease, 17. SAGE Publications Ltd
ISSN: 1479-9723
Popis: We used a pragmatic randomised controlled trial to evaluate a behavioural change strategy targeting carers of chronically hypoxaemic patients using long-term home oxygen therapy. Intervention group carers participated in personalised educational sessions focusing on motivating carers to take actions to assist patients. All patients received usual care. Effectiveness was measured through a composite event of patient survival to hospitalisation, residential care admission or death to 12 months. Secondary outcomes at baseline, 3, 6 and 12 months included carer and patient emotional and physical well-being. No difference between intervention ( n = 100) and control ( n = 97) patients was found for the composite outcome (hazard ratio (HR) 1.22, 95% confidence interval (CI) = 0.89, 1.68; p = 0.22). Improved fatigue, mastery, vitality and general health occurred in intervention group patients (all p values < 0.05). No benefits were seen in carer outcomes. Mortality was significantly higher in intervention patients (HR = 2.01, 95% CI = 1.00, 4.14; p = 0.05; adjusted for Australia-modified Karnofsky Performance Status), with a significant diagnosis–intervention interaction ( p = 0.028) showing higher mortality in patients with COPD (HR 4.26; 95% CI = 1.60, 11.35) but not those with interstitial lung disease (HR 0.83; 95% CI = 0.28, 2.46). No difference was detected in the primary outcome, but patient mortality was higher when carers had received the intervention, especially in the most disabled patients. Trials examining behavioural change interventions in severe disease should stratify for functionality, and both risks and benefits should be independently monitored. Trial registration: Australian New Zealand Clinical Trials Registry (ACTRN12607000177459).
Databáze: OpenAIRE